tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ValiRx’s Cytolytix Advances Cancer Therapeutics with Key Patent and Platform Developments
Company AnnouncementsValiRx’s Cytolytix Advances Cancer Therapeutics with Key Patent and Platform Developments
13d ago
ValiRx Expands Prostate Cancer Portfolio with New Subsidiary
PremiumCompany Announcements
ValiRx Expands Prostate Cancer Portfolio with New Subsidiary
19d ago
ValiRx Secures Grant to Advance Cancer Research with Open University
PremiumCompany Announcements
ValiRx Secures Grant to Advance Cancer Research with Open University
1M ago
ValiRx Updates Evaluation Agreement with Stingray Bio for Cancer Therapeutics
PremiumCompany Announcements
ValiRx Updates Evaluation Agreement with Stingray Bio for Cancer Therapeutics
1M ago
ValiRx Enters Licensing Agreement with Dominion Biotech for PredictRx Platform
PremiumCompany Announcements
ValiRx Enters Licensing Agreement with Dominion Biotech for PredictRx Platform
1M ago
ValiRx Partners with VoxCell for Advanced Cancer Model Development
PremiumCompany AnnouncementsValiRx Partners with VoxCell for Advanced Cancer Model Development
2M ago
ValiRx PLC Announces Successful AGM Resolution Outcomes
Premium
Company Announcements
ValiRx PLC Announces Successful AGM Resolution Outcomes
3M ago
ValiRx Secures £16 Million Licensing Deal with Ambrose Healthcare for VAL401
Premium
Company Announcements
ValiRx Secures £16 Million Licensing Deal with Ambrose Healthcare for VAL401
3M ago
ValiRx Announces Post-Results Investor Webinar with CEO
PremiumCompany Announcements
ValiRx Announces Post-Results Investor Webinar with CEO
3M ago
ValiRx PLC Reports 2024 Financial Results and Strategic Restructuring
PremiumCompany Announcements
ValiRx PLC Reports 2024 Financial Results and Strategic Restructuring
3M ago
ValiRx and Omios Biologics Collaborate on Oncolytic Cancer Therapies
PremiumCompany Announcements
ValiRx and Omios Biologics Collaborate on Oncolytic Cancer Therapies
3M ago
ValiRx plc Announces Significant Shareholder Voting Rights Change
PremiumCompany Announcements
ValiRx plc Announces Significant Shareholder Voting Rights Change
4M ago
ValiRx Extends Drug Repurposing Deal with Dominion Biotech
PremiumCompany AnnouncementsValiRx Extends Drug Repurposing Deal with Dominion Biotech
4M ago
ValiRx Expands Cancer Therapeutics Through Strategic Partnerships
Premium
Company Announcements
ValiRx Expands Cancer Therapeutics Through Strategic Partnerships
5M ago
ValiRx Terminates LOI with TheoremRx, Focuses on Prostate Cancer Asset
Premium
Company Announcements
ValiRx Terminates LOI with TheoremRx, Focuses on Prostate Cancer Asset
5M ago
ValiRx Announces Board Restructuring and New Advisory Board Formation
PremiumCompany Announcements
ValiRx Announces Board Restructuring and New Advisory Board Formation
6M ago
ValiRx Issues Director Disclosure Update Amid Oncimmune Developments
PremiumCompany Announcements
ValiRx Issues Director Disclosure Update Amid Oncimmune Developments
6M ago
ValiRx Concludes Drug Evaluation Project with Imperial College
PremiumCompany Announcements
ValiRx Concludes Drug Evaluation Project with Imperial College
7M ago
ValiRx Partners with Screenin3D for Advanced Cancer Research
PremiumCompany Announcements
ValiRx Partners with Screenin3D for Advanced Cancer Research
7M ago
ValiRx Extends Evaluation Agreement for Cancer Therapeutics Research
PremiumCompany AnnouncementsValiRx Extends Evaluation Agreement for Cancer Therapeutics Research
8M ago
ValiRx Partners with Altus for Innovative Cancer Treatment Evaluation
Premium
Company Announcements
ValiRx Partners with Altus for Innovative Cancer Treatment Evaluation
8M ago
ValiRx PLC Announces Change in Major Holdings
Premium
Company Announcements
ValiRx PLC Announces Change in Major Holdings
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >